Authors:
Chiaramonte, MG
Cheever, AW
Malley, JD
Donaldson, DD
Wynn, TA
Citation: Mg. Chiaramonte et al., Studies of murine schistosomiasis reveal interleukin-13 blockade as a treatment for established and progressive liver fibrosis, HEPATOLOGY, 34(2), 2001, pp. 273-282
Authors:
Vaillant, B
Chiaramonte, MG
Cheever, AW
Soloway, PD
Wynn, TA
Citation: B. Vaillant et al., Regulation of hepatic fibrosis and extracellular matrix genes by the Th response: New insight into the role of tissue inhibitors of matrix metalloproteinases, J IMMUNOL, 167(12), 2001, pp. 7017-7026
Authors:
Chiaramonte, MG
Hesse, M
Cheever, AW
Wynn, TA
Citation: Mg. Chiaramonte et al., CpG oligonucleotides can prophylactically immunize against Th2-mediated schistosome egg-induced pathology by an IL-12-independent mechanism, J IMMUNOL, 164(2), 2000, pp. 973-985
Authors:
Chiaramonte, MG
Schopf, LR
Neben, TY
Cheever, AW
Donaldson, DD
Wynn, TA
Citation: Mg. Chiaramonte et al., IL-13 is a key regulatory cytokine for Th2 cell-mediated pulmonary granuloma formation and IgE responses induced by Schistosoma mansoni eggs, J IMMUNOL, 162(2), 1999, pp. 920-930
Authors:
Chiaramonte, MG
Donaldson, DD
Cheever, AW
Wynn, TA
Citation: Mg. Chiaramonte et al., An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response, J CLIN INV, 104(6), 1999, pp. 777-785
Authors:
Kaplan, D
Baldi, C
Chiaramonte, MG
Fernandez, MM
Levin, MJ
Malchiodi, E
Baldi, A
Citation: D. Kaplan et al., Expression of a recombinant Fab antibody fragment against cruzipain, the major cysteine proteinase of Trypanosoma cruzi, BIOC BIOP R, 253(1), 1998, pp. 53-58